507486
CAPRO
Start SIP
Invest Now
Start SIP in CAPRO
Performance
- Low
- ₹71
- High
- ₹71
- 52 Week Low
- ₹38
- 52 Week High
- ₹71
- Open Price₹71
- Previous Close₹68
- Volume1,273
- 50 DMA₹54.96
- 100 DMA₹51.46
- 200 DMA₹49.37
Investment Returns
- Over 1 Month + 19.21%
- Over 3 Month + 66.15%
- Over 6 Month + 67.68%
- Over 1 Year + 47.57%
Smart Investing Starts Here Start SIP with Caprolactam Chemicals for Steady Growth!
Caprolactam Chemicals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 6145.8
- PEG Ratio
- 60.3
- Market Cap Cr
- 33
- P/B Ratio
- 6.2
- Average True Range
- 3.13
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 1.17
- RSI
- 74.49
- MFI
- 85.82
Caprolactam Chemicals Financials
Caprolactam Chemicals Technicals
EMA & SMA
Current Price
₹71.23
+
3.39
(5%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹58.69
- 50 Day
- ₹54.96
- 100 Day
- ₹51.46
- 200 Day
- ₹49.37
Resistance and Support
71.23
- R3 71.23
- R2 71.23
- R1 71.23
- S1 71.23
- S2 71.23
- S3 71.23
Caprolactam Chemicals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results | |
| 2025-08-14 | Quarterly Results | |
| 2025-05-30 | Audited Results | |
| 2025-02-14 | Quarterly Results | |
| 2024-11-12 | Quarterly Results |
Caprolactam Chemicals F&O
About Caprolactam Chemicals
- NSE Symbol
- CAPRO
- BSE Symbol
- 507486
- Chairperson & Managing Director
- Mrs. Zaver Shankarlal Bhanushali
- ISIN
- INE470N01010
Similar Stocks to Caprolactam Chemicals
Caprolactam Chemicals FAQs
Caprolactam Chemicals share price is ₹71 As on 14 January, 2026 | 19:34
The Market Cap of Caprolactam Chemicals is ₹32.8 Cr As on 14 January, 2026 | 19:34
The P/E ratio of Caprolactam Chemicals is 6145.8 As on 14 January, 2026 | 19:34
The PB ratio of Caprolactam Chemicals is 6.2 As on 14 January, 2026 | 19:34
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.